Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

835 ARTÍCULOS , VIENDO DEL 736 AL 750

SPG7-Related Neurologic Disorder

Hedera P.

2006 Aug 24 [updated 2026 Jan 8]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

PLA2G6-Associated Neurodegeneration

Gregory A, Kurian MA, Soo AKS, Wilson JL, Hogarth P, Hayflick SJ.

2008 Jun 19 [updated 2026 Apr 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients

Quiroz V, Alecu JE, Zubair U, Bernardi K, Zaman Z, Rong J, Tam A, Kunta A, Agianda HAP, Battaglia N, Schmidt HJD, Resch D, Wyman N, Vogt LM, Uraba WB, Becker LF, Kothur K, Gill D, Suarez B, Jofre JI, Arias C, Castiglioni C, da Silva Möller PD, Pinto Duarte AF, Eggers-Lisboa A, Ríos-Pohl L, Gonzalez-Ubilla M, Chaudhari C, Salazar-Villacorta A, Tian X, Dai L, Ding C, Zamani M, Nourbakhsh P, Shariati G, Pringsheim T, Lim WK, Bartolini E, Stamelou M, Bhatia P, Kruer MC, Desai S, Iype M, Necpál J, Crosiers D, Jones HF, Perez-Sanchez JR, Unal ED, Lopez-Ariztegui N, Kola S, Lin WS, Mansour AH, Triki CC, Fernandez-Alvarez E, Roze E, Sahu JK, Doja A, Nardocci N, Caputo D, Koy A, Bhate S, Kaliakatsos M, Robinson R, Hassell J, Pons R, Munchau A, Soliani L, Zea-Vera A, Tochen L, Morales-Briceño H, Dale RC, D'Gama A, Loddenkemper T, Pearl PL, Mohammad SS, Kurian MA, Gorodetsky C, Ortigoza-Escobar JD, Schierbaum L, Yang K, Ebrahimi-Fakhari D.

Brain. 2026 Feb 7;149(2):563-578. doi: 10.1093/brain/awaf297.

Beta-Mannosidosis

Martin Rios A, Kimonis V.

2026 May 19. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Cerebrotendinous Xanthomatosis

Patni N, Wilson DP.

2026 Apr 12. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.

Biotinidase Deficiency

Wolf B.

2000 Mar 24 [updated 2026 Feb 19]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Flow diversion jet: A dangerous mechanism in the flow diversion treatment of giant intracranial aneurysms

Brake A, Fry L, Heskett C, De Stefano FA, Lei C, Ebersole K.

Interv Neuroradiol. 2026 Feb;32(1):134-141. doi: 10.1177/15910199231175622. Epub 2023 May 11.

TUBB4A-Related Neurologic Disorders

Gavazzi F, Pizzino A, Bally JF, Fraser J, Simons C, Wolf NI, van der Knaap M, Vanderver A.

2016 Nov 3 [updated 2026 Mar 5]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Mechanisms of pacemaking in mammalian neurons

Bean BP.

J Physiol. 2026 May;604(9):3533-3547. doi: 10.1113/JP284759. Epub 2024 Sep 20.

Efficacy and safety of cenobamate in developmental and epileptic encephalopathies: A systematic review and meta-analysis

Samanta D, Naik S.

Seizure. 2026 Jan;134:86-96. doi: 10.1016/j.seizure.2025.11.016. Epub 2025 Nov 23.

First-in-human high dose AAV9 intrathecal gene therapy for paediatric CLN7 disease: a phase 1, open-label, single ascending dose, non-randomised clinical trial

Greenberg BM, Minassian B, Messahel S, Edgar VB, Lowden A, Dahshi H, Nettesheim ER, Nguyen HH, Hughes S, Muthukumar AR, Srinivasan K, Iannaccone S, Varadarajan G, Gray SJ, Kayani SN.

EBioMedicine. 2026 Jan;123:106044. doi: 10.1016/j.ebiom.2025.106044. Epub 2025 Nov 27.

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250)

Navarro A, Thomas A, Cheng Y, Chen Y, Reguart N, Yoshida T, Cousin S, Dong X, Yamamoto N, Cappuzzo F, Hallwachs R, Bolleddula J, Sarholz B, Grombacher T, Otte M, Gounaris I, Ferrer J, Moulin C, Paz-Ares L.

ESMO Open. 2026 Jan;11(1):105918. doi: 10.1016/j.esmoop.2025.105918. Epub 2025 Dec 19.

SNUPN-Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Muelas N, Iruzubieta P, Damborenea A, Pérez-Fernández L, Azorín I, Jiménez García JC, Töpf A, Martí P, Fores-Toribio L, Manterola M, Blanco-Mañez R, Pikatza-Menoio O, Alonso-Martín S, Straub V, Cortajarena AL, López de Munain A, De Sancho D, Blázquez L, Vilchez JJ.

Ann Clin Transl Neurol. 2026 Feb;13(2):285-295. doi: 10.1002/acn3.70211. Epub 2025 Oct 6.

Clinical and molecular variations in Burkitt lymphoma

O'Connor E, Scanlan P, Smith OP, Halasz M.

Transl Oncol. 2026 Jan;63:102611. doi: 10.1016/j.tranon.2025.102611. Epub 2025 Nov 25.

Phenotypic spectrum, etiology and outcomes of infection-related movement disorders: An observational cohort study

Garg D, Makharia A, Agarwal A, Mustafa F, Radhakrishnan DM, Rajan R, Srivastava AK.

Parkinsonism Relat Disord. 2026 Jan;142:108135. doi: 10.1016/j.parkreldis.2025.108135. Epub 2025 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias